InVivo Therapeutics Treats the Spinal Cord Itself, A Novel Technology
Frank Reynolds, President and CEO of InVivo Therapeutics describes the company’s strategy in bringing its unique spinal cord injury (SPI) products to market.
Articles by Herina Ayot
August 17, 2011 NYBA Dog Days of Summer Networker
Get out of the heat and into a dry martini at NYBA’s annual celebration of summer!
Editor’s Note August 8, 2011
We recently introduced OneMedRadio a product designed to bring our readers interviews with the CEOs and investors building some of the most innovative companies in […]
Dr. Jun Ma Discusses Biox Monitors and Future of Cardiac Care
Vasomedical (OTC: VASO) President & CEO Jun Ma, Ph.D., was interviewed by OneMedRadio. Vasomedical is a Westbury, New York device company with a market cap of $39M focusing on cardiac disease.
January 9-12, 2012 OneMedForum San Francisco
The 5th Annual OneMedForum San Francisco 2012 is around the corner and builds on the success and recognition of four previous San Francisco Forums and two recently launched in New York City.
Keating Capital Raises $86 million to fund Pre-IPO companies.
Keating Capital’s President Timothy Keating was interviewed by OneMedRadio where he describes the liquidity premium that gives public companies 3x valuation over private company peers and the dramatic decline in IPOs and increase in size that is debilitating economic growth.
Arun Menawat Discusses Novadaq Technologies, a Surgical Imaging Company
Novadaq Technologies (TSX:NDQ) President & CEO Arun Menawat, Ph.D was interviewed by OneMedRadio and discusses the roll out of his surgical imaging technology.
Jason Napodano Discusses ISCO’s Stem Cell Development and Recent Research Report
Zack’s Investment Research’s Senior Biotech Analyst, Jason Napodano, was interviewed by OneMedRadio where he discussed International Stem Cell Corp [OTC:ISCO].
OneMedPlace Launches OneMedRadio to Expand Coverage of Public Companies
OneMedPlace (OMP) announced the creation of OneMedRadio to anchor an expansion of coverage on small public companies in the healthcare and life sciences sector.